Paclitaxel -Protein Bound Particles (PBP)

Severe Myelosuppression

  • Do not administer ABRAXANE therapy to patients who have baseline neutrophil counts of less than 1,500 cells/mm3.

Monitoring data

  • Monitor for neutropenia, which may be severe and result in infection or sepsis, it is recommended that frequent.

  • Perform frequent complete blood cell counts on all patients receiving ABRAXANE 

Package inserts

Updated: January 2023